Physiological Intermolecular Modification Spectroscopy for the Prediction of Response to Anti-Tumor Necrosis Factor Therapy in Patients with Inflammatory Bowel Diseases

Tumor Necrosis ◽

Prediction Of Response ◽

Bowel Diseases ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Listeria monocytogenes infection in patients with inflammatory bowel diseases receiving anti-tumor necrosis factor therapy

Revista Española de Enfermedades Digestivas ◽

10.4321/s1130-01082010001000014 ◽

2010 ◽

Vol 102 (10) ◽

Cited By ~ 9

Author(s):

J. M. Ramos ◽

M. F. García-Sepulcre ◽

M. Masiá ◽

A. Brotons ◽

M. C. Grau ◽

...

Keyword(s):

Listeria Monocytogenes ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Listeria Monocytogenes Infection ◽

Bowel Diseases ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Inflammatory Cytokines in Patients with Inflammatory Bowel Diseases That Donʼt Respond to Optimal Anti-Tumor Necrosis Factor Therapy

The American Journal of Gastroenterology ◽

10.14309/00000434-201610001-00740 ◽

2016 ◽

Vol 111 ◽

pp. S332-S333

Author(s):

Andres Yarur ◽

Anjali Jain ◽

Maria Alejandra Quintero ◽

Maria T. Abreu

Keyword(s):

Tumor Necrosis Factor ◽

Inflammatory Cytokines ◽

Tumor Necrosis ◽

Bowel Diseases ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Anti–Tumor Necrosis Factor Therapy Restores Peripheral Blood B-cell Subsets and CD40 Expression in Inflammatory Bowel Diseases

10.1097/mib.0000000000000554 ◽

2015 ◽

Vol 21 (12) ◽

pp. 2787-2796 ◽

Cited By ~ 18

Author(s):

Zhe Li ◽

Séverine Vermeire ◽

Dominique Bullens ◽

Marc Ferrante ◽

Kristel Van Steen ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

B Cell ◽

Tumor Necrosis ◽

Bowel Diseases ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Cd40 Expression ◽

B Cell Subsets ◽

Restoration of Foxp3+ Regulatory T-cell Subsets and Foxp3− Type 1 Regulatory-like T Cells in Inflammatory Bowel Diseases During Anti-tumor Necrosis Factor Therapy

10.1097/mib.0000000000000509 ◽

2015 ◽

pp. 1 ◽

Cited By ~ 2

Author(s):

Zhe Li ◽

Séverine Vermeire ◽

Dominique Bullens ◽

Marc Ferrante ◽

Kristel Van Steen ◽

...

Keyword(s):

T Cells ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

T Cell Subsets ◽

Bowel Diseases ◽

Factor Therapy ◽

Inflammatory Bowel ◽

Diagnosis and Treatment of Latent Tuberculosis Infection in Patients with Inflammatory Bowel Diseases due to Initiation of Anti-Tumor Necrosis Factor Therapy

Intestinal Research ◽

10.5217/ir.2014.12.1.12 ◽

2014 ◽

Vol 12 (1) ◽

pp. 12 ◽

Cited By ~ 22

Author(s):

Tae Sun Shim

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Latent Tuberculosis Infection ◽

Latent Tuberculosis ◽

Diagnosis And Treatment ◽

Bowel Diseases ◽

Factor Therapy ◽

Inflammatory Bowel ◽

P154 PRIMARY NON-RESPONSE TO TUMOR NECROSIS FACTOR ANTAGONISTS IS ASSOCIATED WITH INFERIOR RESPONSE TO SECOND-LINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS

Gastroenterology ◽

10.1053/j.gastro.2017.11.204 ◽

2018 ◽

Vol 154 (1) ◽

pp. S81-S82

Author(s):

Siddharth Singh ◽

John George ◽

Brigid S. Boland ◽

Niels Vande Casteele ◽

William J. Sandborn

Keyword(s):

Systematic Review ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Second Line ◽

Tumor Necrosis Factor Antagonists ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

S0861 Comparative Risk of Serious Infections With Tumor Necrosis Factor-α Antagonists vs Vedolizumab in Patients With Inflammatory Bowel Diseases

The American Journal of Gastroenterology ◽

10.14309/01.ajg.0000705492.87799.ce ◽

2020 ◽

Vol 115 (1) ◽

pp. S444-S445

Author(s):

Siddharth Singh ◽

Herbert Heien ◽

Jeph Herrin ◽

Parambir S. Dulai ◽

Lindsey Sangaralingham ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Tumor Necrosis Factor Α ◽

Serious Infections ◽

Bowel Diseases ◽

Comparative Risk ◽

Inflammatory Bowel ◽

Factor Α ◽

Neurological Adverse Effects Associated With Anti-tumor Necrosis Factor Alpha Antibodies in Pediatric Inflammatory Bowel Diseases

Journal of Pediatric Gastroenterology and Nutrition ◽

10.1097/mpg.0000000000002654 ◽

2020 ◽

Vol 70 (6) ◽

pp. 841-848

Author(s):

Valérie Bertrand ◽

Nathalie Massy ◽

Bénédicte Pigneur ◽

Stéphanie Coopman ◽

Geneviève Durrieu ◽

...

Keyword(s):

Tumor Necrosis Factor ◽

Adverse Effects ◽

Tumor Necrosis Factor Alpha ◽

Tumor Necrosis ◽

Necrosis Factor Alpha ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Factor Alpha ◽

P154 PRIMARY NON-RESPONSE TO TUMOR NECROSIS FACTOR ANTAGONISTS IS ASSOCIATED WITH INFERIOR RESPONSE TO SECOND-LINE BIOLOGICS IN PATIENTS WITH INFLAMMATORY BOWEL DISEASES: A SYSTEMATIC REVIEW AND META-ANALYSIS

10.1093/ibd/izy037.025 ◽

2018 ◽

Vol 24 (suppl_1) ◽

pp. S57-S57

Author(s):

Siddharth Singh ◽

John George ◽

Brigid S Boland ◽

Niels Vande Casteele ◽

William J Sandborn

Keyword(s):

Systematic Review ◽

Tumor Necrosis Factor ◽

Tumor Necrosis ◽

Meta Analysis ◽

Second Line ◽

Tumor Necrosis Factor Antagonists ◽

Bowel Diseases ◽

Inflammatory Bowel ◽

Molecular mechanism of action of anti-tumor necrosis factor antibodies in inflammatory bowel diseases

World Journal of Gastroenterology ◽

10.3748/wjg.v22.i42.9300 ◽

2016 ◽

Vol 22 (42) ◽

pp. 9300 ◽

Cited By ~ 71

Author(s):

Ulrike Billmeier ◽

Walburga Dieterich ◽

Markus F Neurath ◽

Raja Atreya

Keyword(s):

Tumor Necrosis Factor ◽

Molecular Mechanism ◽

Mechanism Of Action ◽

Tumor Necrosis ◽

Bowel Diseases ◽

Molecular Mechanism Of Action ◽

Inflammatory Bowel ◽